Risk For Below Knee Amputations With Canagliflozin Vs Other Antihyperglycemic Agents | Latest News RSS feed

Risk For Below Knee Amputations With Canagliflozin Vs Other Antihyperglycemic Agents - Latest News


INVOKANA® (canagliflozin) Demonstrates Cardiovascular (CV) Risk Reductions in Type 2 Diabetes Patients With and Without a History of Prior CV Events

Comparable effects were also observed for other CV and renal ... had at least two CV risk factors. The study assessed the safety of canagliflozin relative to placebo in patients receiving specific com... read more

Dr. John Buse

Dr. Buse accepts several types of health insurance, listed below. He is one of 16 doctors at University of North Carolina Hospitals who specialize in Endocrinology, Diabetes & Metabolism. read more

The Triple Aim: Care, Health, And Cost

Improving the U.S. health care system requires simultaneous pursuit of three aims: improving the experience of care, improving the health of populations, and reducing per capita costs of health care. ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us